GPC3 reduces cell proliferation in renal carcinoma cell lines

Glypican 3 (GPC3) is a member of the family of glypican heparan sulfate proteoglycans (HSPGs). The GPC3 gene may play a role in controlling cell migration, negatively regulating cell growth and inducing apoptosis. GPC3 is downregulated in several cancers, which can result in uncontrolled cell growth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2014-08, Vol.14 (1), p.631-631, Article 631
Hauptverfasser: Valsechi, Marina Curado, Oliveira, Ana Beatriz Bortolozo, Conceição, André Luis Giacometti, Stuqui, Bruna, Candido, Natalia Maria, Provazzi, Paola Jocelan Scarin, de Araújo, Luiza Ferreira, Silva, Jr, Wilson Araújo, Calmon, Marilia de Freitas, Rahal, Paula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 631
container_issue 1
container_start_page 631
container_title BMC cancer
container_volume 14
creator Valsechi, Marina Curado
Oliveira, Ana Beatriz Bortolozo
Conceição, André Luis Giacometti
Stuqui, Bruna
Candido, Natalia Maria
Provazzi, Paola Jocelan Scarin
de Araújo, Luiza Ferreira
Silva, Jr, Wilson Araújo
Calmon, Marilia de Freitas
Rahal, Paula
description Glypican 3 (GPC3) is a member of the family of glypican heparan sulfate proteoglycans (HSPGs). The GPC3 gene may play a role in controlling cell migration, negatively regulating cell growth and inducing apoptosis. GPC3 is downregulated in several cancers, which can result in uncontrolled cell growth and can also contribute to the malignant phenotype of some tumors. The purpose of this study was to analyze the mechanism of action of the GPC3 gene in clear cell renal cell carcinoma. Five clear cell renal cell carcinoma cell lines and carcinoma samples were used to analyze GPC3 mRNA expression (qRT-PCR). Then, representative cell lines, one primary renal carcinoma (786-O) and one metastatic renal carcinoma (ACHN), were chosen to carry out functional studies. We constructed a GPC3 expression vector and transfected the renal carcinoma cell lines, 786-O and ACHN. GPC3 overexpression was analyzed using qRT-PCR and immunocytochemistry. We evaluated cell proliferation using MTT and colony formation assays. Flow cytometry was used to evaluate apoptosis and perform cell cycle analyses. We observed that GPC3 is downregulated in clear cell renal cell carcinoma samples and cell lines compared with normal renal samples. GPC3 mRNA expression and protein levels in 786-O and ACHN cell lines increased after transfection with the GPC3 expression construct, and the cell proliferation rate decreased in both cell lines following overexpression of GPC3. Further, apoptosis was not induced in the renal cell carcinoma cell lines overexpressing GPC3, and there was an increase in the cell population during the G1 phase in the cell cycle. We suggest that the GPC3 gene reduces the rate of cell proliferation through cell cycle arrest during the G1 phase in renal cell carcinoma.
doi_str_mv 10.1186/1471-2407-14-631
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4161903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1561467177</sourcerecordid><originalsourceid>FETCH-LOGICAL-b484t-9444ede247ff393494c755555ae5b09b3ef9b408b352f4b949758c03add8ea643</originalsourceid><addsrcrecordid>eNp1kc1LxDAQxYMoun7cPUnBi5dqppkm7UFBFr9gQQ96Dmmaapa2WZOt4H9vS9dlFc0lw8zL4-U3hBwDPQfI-AWggDhBKmLAmDPYIpN1a3uj3iP7IcwpBZHRbJfsJSnwDDifkMu7pymLvCk7bUKkTV1HC-9qWxmvlta1kW37aavqSCuvbesaNapq25pwSHYqVQdztLoPyMvtzfP0Pp493j1Mr2dxgRku4xwRTWkSFFXFcoY5apEOR5m0oHnBTJUXSLOCpUmFRY65SDNNmSrLzCiO7IBcjb6LrmhMqU279KqWC28b5T-lU1b-nLT2Tb66D4nAIaesN5iOBoV1_xj8nGjXyAGfHPD1lezp9i5nqxjevXcmLGVjw0BDtcZ1QULKAbkAIXrp6S_p3HW-5ziqIIU0Gf5FR5X2LgRvqnUioHLY8F8ZTjZRrB98r5R9AWosoDY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1561151524</pqid></control><display><type>article</type><title>GPC3 reduces cell proliferation in renal carcinoma cell lines</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Valsechi, Marina Curado ; Oliveira, Ana Beatriz Bortolozo ; Conceição, André Luis Giacometti ; Stuqui, Bruna ; Candido, Natalia Maria ; Provazzi, Paola Jocelan Scarin ; de Araújo, Luiza Ferreira ; Silva, Jr, Wilson Araújo ; Calmon, Marilia de Freitas ; Rahal, Paula</creator><creatorcontrib>Valsechi, Marina Curado ; Oliveira, Ana Beatriz Bortolozo ; Conceição, André Luis Giacometti ; Stuqui, Bruna ; Candido, Natalia Maria ; Provazzi, Paola Jocelan Scarin ; de Araújo, Luiza Ferreira ; Silva, Jr, Wilson Araújo ; Calmon, Marilia de Freitas ; Rahal, Paula</creatorcontrib><description>Glypican 3 (GPC3) is a member of the family of glypican heparan sulfate proteoglycans (HSPGs). The GPC3 gene may play a role in controlling cell migration, negatively regulating cell growth and inducing apoptosis. GPC3 is downregulated in several cancers, which can result in uncontrolled cell growth and can also contribute to the malignant phenotype of some tumors. The purpose of this study was to analyze the mechanism of action of the GPC3 gene in clear cell renal cell carcinoma. Five clear cell renal cell carcinoma cell lines and carcinoma samples were used to analyze GPC3 mRNA expression (qRT-PCR). Then, representative cell lines, one primary renal carcinoma (786-O) and one metastatic renal carcinoma (ACHN), were chosen to carry out functional studies. We constructed a GPC3 expression vector and transfected the renal carcinoma cell lines, 786-O and ACHN. GPC3 overexpression was analyzed using qRT-PCR and immunocytochemistry. We evaluated cell proliferation using MTT and colony formation assays. Flow cytometry was used to evaluate apoptosis and perform cell cycle analyses. We observed that GPC3 is downregulated in clear cell renal cell carcinoma samples and cell lines compared with normal renal samples. GPC3 mRNA expression and protein levels in 786-O and ACHN cell lines increased after transfection with the GPC3 expression construct, and the cell proliferation rate decreased in both cell lines following overexpression of GPC3. Further, apoptosis was not induced in the renal cell carcinoma cell lines overexpressing GPC3, and there was an increase in the cell population during the G1 phase in the cell cycle. We suggest that the GPC3 gene reduces the rate of cell proliferation through cell cycle arrest during the G1 phase in renal cell carcinoma.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/1471-2407-14-631</identifier><identifier>PMID: 25168166</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Apoptosis ; Breast cancer ; Carcinoma, Renal Cell - genetics ; Carcinoma, Renal Cell - metabolism ; Carcinoma, Renal Cell - pathology ; Cell Cycle ; Cell growth ; Cell Line, Tumor ; Cell Proliferation ; Deoxyribonucleic acid ; DNA ; Extracellular matrix ; Female ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genomics ; Glypicans - genetics ; Glypicans - metabolism ; Humans ; Kidney Neoplasms - genetics ; Kidney Neoplasms - metabolism ; Kidney Neoplasms - pathology ; Liver cancer ; Male ; Metastasis ; Middle Aged ; Polymerase chain reaction ; Real time ; Rodents ; Studies ; Tumors</subject><ispartof>BMC cancer, 2014-08, Vol.14 (1), p.631-631, Article 631</ispartof><rights>2014 Valsechi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Valsechi et al.; licensee BioMed Central Ltd. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b484t-9444ede247ff393494c755555ae5b09b3ef9b408b352f4b949758c03add8ea643</citedby><cites>FETCH-LOGICAL-b484t-9444ede247ff393494c755555ae5b09b3ef9b408b352f4b949758c03add8ea643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161903/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161903/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25168166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valsechi, Marina Curado</creatorcontrib><creatorcontrib>Oliveira, Ana Beatriz Bortolozo</creatorcontrib><creatorcontrib>Conceição, André Luis Giacometti</creatorcontrib><creatorcontrib>Stuqui, Bruna</creatorcontrib><creatorcontrib>Candido, Natalia Maria</creatorcontrib><creatorcontrib>Provazzi, Paola Jocelan Scarin</creatorcontrib><creatorcontrib>de Araújo, Luiza Ferreira</creatorcontrib><creatorcontrib>Silva, Jr, Wilson Araújo</creatorcontrib><creatorcontrib>Calmon, Marilia de Freitas</creatorcontrib><creatorcontrib>Rahal, Paula</creatorcontrib><title>GPC3 reduces cell proliferation in renal carcinoma cell lines</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>Glypican 3 (GPC3) is a member of the family of glypican heparan sulfate proteoglycans (HSPGs). The GPC3 gene may play a role in controlling cell migration, negatively regulating cell growth and inducing apoptosis. GPC3 is downregulated in several cancers, which can result in uncontrolled cell growth and can also contribute to the malignant phenotype of some tumors. The purpose of this study was to analyze the mechanism of action of the GPC3 gene in clear cell renal cell carcinoma. Five clear cell renal cell carcinoma cell lines and carcinoma samples were used to analyze GPC3 mRNA expression (qRT-PCR). Then, representative cell lines, one primary renal carcinoma (786-O) and one metastatic renal carcinoma (ACHN), were chosen to carry out functional studies. We constructed a GPC3 expression vector and transfected the renal carcinoma cell lines, 786-O and ACHN. GPC3 overexpression was analyzed using qRT-PCR and immunocytochemistry. We evaluated cell proliferation using MTT and colony formation assays. Flow cytometry was used to evaluate apoptosis and perform cell cycle analyses. We observed that GPC3 is downregulated in clear cell renal cell carcinoma samples and cell lines compared with normal renal samples. GPC3 mRNA expression and protein levels in 786-O and ACHN cell lines increased after transfection with the GPC3 expression construct, and the cell proliferation rate decreased in both cell lines following overexpression of GPC3. Further, apoptosis was not induced in the renal cell carcinoma cell lines overexpressing GPC3, and there was an increase in the cell population during the G1 phase in the cell cycle. We suggest that the GPC3 gene reduces the rate of cell proliferation through cell cycle arrest during the G1 phase in renal cell carcinoma.</description><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Carcinoma, Renal Cell - genetics</subject><subject>Carcinoma, Renal Cell - metabolism</subject><subject>Carcinoma, Renal Cell - pathology</subject><subject>Cell Cycle</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Extracellular matrix</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genomics</subject><subject>Glypicans - genetics</subject><subject>Glypicans - metabolism</subject><subject>Humans</subject><subject>Kidney Neoplasms - genetics</subject><subject>Kidney Neoplasms - metabolism</subject><subject>Kidney Neoplasms - pathology</subject><subject>Liver cancer</subject><subject>Male</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Polymerase chain reaction</subject><subject>Real time</subject><subject>Rodents</subject><subject>Studies</subject><subject>Tumors</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kc1LxDAQxYMoun7cPUnBi5dqppkm7UFBFr9gQQ96Dmmaapa2WZOt4H9vS9dlFc0lw8zL4-U3hBwDPQfI-AWggDhBKmLAmDPYIpN1a3uj3iP7IcwpBZHRbJfsJSnwDDifkMu7pymLvCk7bUKkTV1HC-9qWxmvlta1kW37aavqSCuvbesaNapq25pwSHYqVQdztLoPyMvtzfP0Pp493j1Mr2dxgRku4xwRTWkSFFXFcoY5apEOR5m0oHnBTJUXSLOCpUmFRY65SDNNmSrLzCiO7IBcjb6LrmhMqU279KqWC28b5T-lU1b-nLT2Tb66D4nAIaesN5iOBoV1_xj8nGjXyAGfHPD1lezp9i5nqxjevXcmLGVjw0BDtcZ1QULKAbkAIXrp6S_p3HW-5ziqIIU0Gf5FR5X2LgRvqnUioHLY8F8ZTjZRrB98r5R9AWosoDY</recordid><startdate>20140829</startdate><enddate>20140829</enddate><creator>Valsechi, Marina Curado</creator><creator>Oliveira, Ana Beatriz Bortolozo</creator><creator>Conceição, André Luis Giacometti</creator><creator>Stuqui, Bruna</creator><creator>Candido, Natalia Maria</creator><creator>Provazzi, Paola Jocelan Scarin</creator><creator>de Araújo, Luiza Ferreira</creator><creator>Silva, Jr, Wilson Araújo</creator><creator>Calmon, Marilia de Freitas</creator><creator>Rahal, Paula</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140829</creationdate><title>GPC3 reduces cell proliferation in renal carcinoma cell lines</title><author>Valsechi, Marina Curado ; Oliveira, Ana Beatriz Bortolozo ; Conceição, André Luis Giacometti ; Stuqui, Bruna ; Candido, Natalia Maria ; Provazzi, Paola Jocelan Scarin ; de Araújo, Luiza Ferreira ; Silva, Jr, Wilson Araújo ; Calmon, Marilia de Freitas ; Rahal, Paula</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b484t-9444ede247ff393494c755555ae5b09b3ef9b408b352f4b949758c03add8ea643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Carcinoma, Renal Cell - genetics</topic><topic>Carcinoma, Renal Cell - metabolism</topic><topic>Carcinoma, Renal Cell - pathology</topic><topic>Cell Cycle</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Extracellular matrix</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genomics</topic><topic>Glypicans - genetics</topic><topic>Glypicans - metabolism</topic><topic>Humans</topic><topic>Kidney Neoplasms - genetics</topic><topic>Kidney Neoplasms - metabolism</topic><topic>Kidney Neoplasms - pathology</topic><topic>Liver cancer</topic><topic>Male</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Polymerase chain reaction</topic><topic>Real time</topic><topic>Rodents</topic><topic>Studies</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valsechi, Marina Curado</creatorcontrib><creatorcontrib>Oliveira, Ana Beatriz Bortolozo</creatorcontrib><creatorcontrib>Conceição, André Luis Giacometti</creatorcontrib><creatorcontrib>Stuqui, Bruna</creatorcontrib><creatorcontrib>Candido, Natalia Maria</creatorcontrib><creatorcontrib>Provazzi, Paola Jocelan Scarin</creatorcontrib><creatorcontrib>de Araújo, Luiza Ferreira</creatorcontrib><creatorcontrib>Silva, Jr, Wilson Araújo</creatorcontrib><creatorcontrib>Calmon, Marilia de Freitas</creatorcontrib><creatorcontrib>Rahal, Paula</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valsechi, Marina Curado</au><au>Oliveira, Ana Beatriz Bortolozo</au><au>Conceição, André Luis Giacometti</au><au>Stuqui, Bruna</au><au>Candido, Natalia Maria</au><au>Provazzi, Paola Jocelan Scarin</au><au>de Araújo, Luiza Ferreira</au><au>Silva, Jr, Wilson Araújo</au><au>Calmon, Marilia de Freitas</au><au>Rahal, Paula</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GPC3 reduces cell proliferation in renal carcinoma cell lines</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2014-08-29</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>631</spage><epage>631</epage><pages>631-631</pages><artnum>631</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Glypican 3 (GPC3) is a member of the family of glypican heparan sulfate proteoglycans (HSPGs). The GPC3 gene may play a role in controlling cell migration, negatively regulating cell growth and inducing apoptosis. GPC3 is downregulated in several cancers, which can result in uncontrolled cell growth and can also contribute to the malignant phenotype of some tumors. The purpose of this study was to analyze the mechanism of action of the GPC3 gene in clear cell renal cell carcinoma. Five clear cell renal cell carcinoma cell lines and carcinoma samples were used to analyze GPC3 mRNA expression (qRT-PCR). Then, representative cell lines, one primary renal carcinoma (786-O) and one metastatic renal carcinoma (ACHN), were chosen to carry out functional studies. We constructed a GPC3 expression vector and transfected the renal carcinoma cell lines, 786-O and ACHN. GPC3 overexpression was analyzed using qRT-PCR and immunocytochemistry. We evaluated cell proliferation using MTT and colony formation assays. Flow cytometry was used to evaluate apoptosis and perform cell cycle analyses. We observed that GPC3 is downregulated in clear cell renal cell carcinoma samples and cell lines compared with normal renal samples. GPC3 mRNA expression and protein levels in 786-O and ACHN cell lines increased after transfection with the GPC3 expression construct, and the cell proliferation rate decreased in both cell lines following overexpression of GPC3. Further, apoptosis was not induced in the renal cell carcinoma cell lines overexpressing GPC3, and there was an increase in the cell population during the G1 phase in the cell cycle. We suggest that the GPC3 gene reduces the rate of cell proliferation through cell cycle arrest during the G1 phase in renal cell carcinoma.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>25168166</pmid><doi>10.1186/1471-2407-14-631</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2407
ispartof BMC cancer, 2014-08, Vol.14 (1), p.631-631, Article 631
issn 1471-2407
1471-2407
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4161903
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Springer Nature OA Free Journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Apoptosis
Breast cancer
Carcinoma, Renal Cell - genetics
Carcinoma, Renal Cell - metabolism
Carcinoma, Renal Cell - pathology
Cell Cycle
Cell growth
Cell Line, Tumor
Cell Proliferation
Deoxyribonucleic acid
DNA
Extracellular matrix
Female
Gene expression
Gene Expression Regulation, Neoplastic
Genomics
Glypicans - genetics
Glypicans - metabolism
Humans
Kidney Neoplasms - genetics
Kidney Neoplasms - metabolism
Kidney Neoplasms - pathology
Liver cancer
Male
Metastasis
Middle Aged
Polymerase chain reaction
Real time
Rodents
Studies
Tumors
title GPC3 reduces cell proliferation in renal carcinoma cell lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A26%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GPC3%20reduces%20cell%20proliferation%20in%20renal%20carcinoma%20cell%20lines&rft.jtitle=BMC%20cancer&rft.au=Valsechi,%20Marina%20Curado&rft.date=2014-08-29&rft.volume=14&rft.issue=1&rft.spage=631&rft.epage=631&rft.pages=631-631&rft.artnum=631&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/1471-2407-14-631&rft_dat=%3Cproquest_pubme%3E1561467177%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1561151524&rft_id=info:pmid/25168166&rfr_iscdi=true